'Brain Tumors Diagnosed in 2 Hours': Groundbreaking Test Speeds Up Detection With Unprecedented Accuracy and Life-Saving Potential
IN A NUTSHELL 🧬 Scientists at the University of Nottingham developed a new method using nanopore sequencing to rapidly read tumor DNA.
to rapidly read tumor DNA. ⏱️ The innovative approach reduces diagnosis time from weeks to as little as two hours , enabling quicker treatment decisions.
, enabling quicker treatment decisions. 💊 Rapid identification of tumor types opens doors to new treatment options and faster access to clinical trials.
and faster access to clinical trials. 💡 The method's cost-effectiveness and efficiency could significantly impact healthcare systems, improving patient care and outcomes.
In the rapidly advancing field of medical technology, a groundbreaking development is poised to transform the way brain tumors are diagnosed and treated. Scientists at the University of Nottingham have devised a method that significantly reduces the time needed to identify tumor types from weeks to mere hours. This innovative approach could potentially save lives by allowing doctors to tailor treatments more swiftly and accurately. The implications of this advancement extend beyond mere speed, impacting the entire process of cancer treatment and patient care. Revolutionizing Tumor DNA Reading
The essence of this innovation lies in nanopore sequencing, a cutting-edge technology that facilitates rapid DNA reading. The process involves passing DNA strands through a device equipped with microscopic holes, or pores. As each strand traverses these pores, the DNA's building blocks are sequenced. The resulting data is then compared against a comprehensive library of known brain tumor types using specialized software. This allows doctors to quickly identify the type of tumor a patient has, often in under two hours.
Cost considerations are also taken into account, with each test priced at approximately $500, aligning with existing genetic testing costs. By potentially replacing four to five separate tests with a single comprehensive one, the method not only speeds up the diagnostic process but also reduces overall costs. Initial trials on 30 archived tumor samples, followed by 50 fresh samples, showed a high accuracy rate, with 90% of new samples correctly identified. Significantly, 76% of fresh samples were identified confidently within an hour, underscoring the method's speed and efficiency.
'Mach 6 From a Runway': US Unveils Hypersonic Jet Engine That Could Redefine Military Airpower and Global Strike Speed Unlocking New Treatment Pathways
Beyond diagnostics, the rapid identification of tumor types can influence surgical decisions during operations. Surgeons can determine whether a more aggressive approach is warranted or if alternative treatments might be more beneficial. As Professor Matthew Loose, a co-author of the study, pointed out, knowing the exact tumor type during surgery could allow for the immediate application of targeted drugs, opening doors to innovative treatment options.
This accelerated diagnostic process also holds promise for clinical trials. By quickly identifying suitable candidates, patients can gain faster access to cutting-edge therapies. The potential to integrate this method into routine clinical practice could revolutionize patient care, providing tailored treatment options much sooner and improving patient outcomes.
'Solid-State Shockwave Hits Battery World': New Tech Supercharges Lithium-Ion Speed by 30% in Unbelievable Energy Leap Implications for Healthcare Systems
The introduction of this rapid testing method could have a profound impact on healthcare systems. By reducing the waiting time for genetic test results, the method not only alleviates patient anxiety but also streamlines clinical workflows. The possibility of diagnosing tumor types before a patient even leaves the operating room could optimize treatment plans from the outset.
Moreover, the cost-effectiveness of this approach could free up resources for other critical areas within healthcare systems. As the method gains traction, it could potentially become a standard practice, benefiting not just individual patients but entire patient populations. The dissemination of this technology could also encourage further research and development in the field of rapid diagnostics.
China Unleashes Next-Gen EREVs With Jaw-Dropping 870-Mile Range and Hesai LiDAR That Could Redefine Autonomous Driving Forever Future Prospects and Ongoing Research
While the initial results are promising, ongoing research is essential to refine the technology and expand its applications. Researchers are exploring the potential to apply similar rapid diagnostic methods to other types of cancer, which could further enhance personalized medicine. The ongoing collaboration between researchers, clinicians, and healthcare providers will be crucial in integrating this technology into everyday medical practice.
The study, published in the journal Neuro-Oncology, marks a significant milestone in cancer research. As healthcare continues to evolve, innovations like these pave the way for more efficient and effective patient care. The journey from laboratory research to clinical application is complex, but the potential benefits make it a pursuit worth undertaking.
This advancement in rapid tumor diagnosis is a testament to the power of technological innovation in healthcare. As researchers continue to push the boundaries of what's possible, one can't help but wonder: What other groundbreaking developments lie on the horizon, waiting to redefine the future of medicine?
Our author used artificial intelligence to enhance this article.
Did you like it? 4.5/5 (22)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
10 hours ago
- Euronews
Hospitals try to waste less laughing gas in bid to curb climate impact
An Irish hospital is trying to prevent unused laughing gas from escaping into the atmosphere, in a bid to curb waste and go green in healthcare. Nitrous oxide, also known as laughing gas, has long been used to relieve pain and relax patients ahead of surgery – but outdated hospital infrastructure means much of the anaesthetic gas is actually wasted and released into the atmosphere, where it remains for around 120 years. That's prompted concerns among health experts across Europe, who say leaks and other efficiency problems are worsening the environmental impact of a sector that is already among the heaviest polluters worldwide. This is 'the most important issue for us to look at by quite some distance,' Dr Paul Southall, sustainability lead for the UK's Royal College of Anaesthetists, told Euronews Health. Now, St John's Hospital in Limerick has become one of the first hospitals in Ireland to stop using nitrous oxide as an anaesthetic on a large scale after deactivating the extensive network of pipes that fed the gas directly to the hospital's operating rooms. 'Nitrous oxide is safe to use, but the infrastructure used to deliver it inevitably results in waste,' said Dr Hugh O'Callaghan, a consultant anaesthetist involved with the St John's project. In a statement, he added that modern methods to deliver anaesthesia are making laughing gas increasingly 'obsolete'. St John's will now rely on mobile equipment to bring anaesthetic cylinders directly into the operating room, according to Ireland's health services agency. Other Irish hospitals in the region are expected to follow suit in the coming months as part of a plan to reduce carbon emissions from anaesthetic gases by 50 per cent by 2030, the agency said. Other European hospitals are also phasing out piped-in methods of delivering laughing gas, including those in the Netherlands and the United Kingdom. In the UK, for example, two hospitals replaced their large centralised nitrous oxide containers with small portable cylinders that could be wheeled into the operating room. This led to a 55 per cent reduction in monthly nitrous oxide emissions, from 333 tonnes to 150 tonnes, according to the National Health Service (NHS) in England. 'It's not about restricting clinical use, it's about creating a less wasteful system,' said Dr Cliff Shelton, a UK-based anaesthetist, professor, and co-chair of the safety, standards, and environmental sustainability committee at the Association of Anaesthetists, a professional group focused on the UK and Ireland. Last year, the group said UK and Irish hospitals should decommission their nitrous oxide pipelines 'as soon as possible,' ideally by 2027. In recent years, the health trust in Manchester, where Shelton works, has switched to a mobile-canister approach for nitrous oxide that he said has reduced the organisation's overall carbon footprint by about three per cent to five per cent. 'We've made it cheaper and greener, and people are still getting the same [anaesthetic] care they always got,' he told Euronews Health. These efforts are part of a broader reckoning among medical workers about how their field is exacerbating climate change, which is linked to a host of health issues, such as asthma, stroke, and mosquito-borne diseases. Globally, the health sector causes 4.4 per cent of net emissions, with the European Union contributing 248 million metric tons of carbon dioxide – behind only the United States and China, according to a 2019 report from the advocacy group Health Care Without Harm. When used as anaesthesia, laughing gas adds an additional one per cent to the EU health sector's carbon footprint, the group found. Other commonly used anaesthetic gases, such as sevoflurane, isoflurane, and desflurane, also contribute. But the vast majority of the health sector's carbon emissions are related to its supply chain – the production, transport, use, and disposal of medicines, medical kits, and other resources. That means minimising waste of nitrous oxide and other gas-based anaesthetics won't be enough for hospitals to offset their climate impact. Even so, sustainability-minded doctors believe it is a good start. 'When we looked into this, we found we were buying 100 times more nitrous oxide than we were actually using,' Shelton said. 'It's a moral imperative, really, to get on top of that [degree of waste],' he added. Organ transplantation, which is often the only way to save a life, is directly dependent on donors. But their sometimes unreliable availability often leads to patients dying before receiving a donated organ. There are two types of organ donations: from a living donor and cadaveric transplants. While options for a living donor are generally restricted to just the kidney and liver, in Kazakhstan it tends to save more lives than a posthumous donation. "Around the world, 80-90% of donations are posthumous, but the same cannot be said about Kazakhstan and the countries in Central Asia. In our country, 80-90% of donors are living relatives of the patients," said Aidar Sitkazinov, Director of the Republican Centre for Coordination of Transplantation and High-Tech Services in Kazakhstan. According to him, the reason many people refuse to donate their organs after death is a lack of trust in the healthcare system. The belief that corruption is everywhere makes them fear that donated organs will be misused or illegally sold, or that doctors will not treat the patients to get to their organs. Sitkazinov notes that selling organs is punishable by law in Kazakhstan. At the same time, dozens of people and several organisations are involved in the procedure for organ transplantation, and hospitals do not benefit monetarily or otherwise if a patient becomes a donor after death. Still, he understands that scandals surrounding organ transplantation often deter people from signing the donation form. Last year alone, there were 15 cases where people attempted to sell donated organs. Religion also plays a role. Many believe Islam or Orthodox Christianity - the two main religions in Central Asia - do not allow posthumous donation. Religious authorities in Kazakhstan all support posthumous donation as a charitable act, but that still has not swayed many people. The religious question is not unique to Kazakhstan or Central Asia. Studies have shown that a reluctance to donate organs after death is a long-standing trend in Islamic countries where living donations prevail. In contrast, in Europe organ donation after death is an established practice, covering up to 50% of the need for organs. Unlike in other parts of the world, Europe also uses organs of donors who died due to heart failure. As of May 2025, 4,226 people in Kazakhstan are on the waiting list for some kind of organ donation, 128 of whom are children. Of the total number of patients, 3,828 are waiting for a kidney, but in the worst case scenario that a donor is not found, those patients also have the option of haemodialysis, which can keep them alive for between 10 and 15 years. "Not everyone who needs an organ transplant is on this list. This category has no other alternative, only an organ transplant can save their lives," highlighted the director of the transplantation coordination body. According to him, on average 300 people die because there simply are not enough organ donors. "I'll give you a simple example – in 2024, we had 86 deceased donors who were diagnosed with brain death. All relatives were approached and only 10 families gave their consent," said Sitkazinov, noting that one deceased person can save seven lives. Kazakhstan has an opt-in consent system, where each citizen has to officially agree to donate their organs after death. However, even if the person gives consent, their relatives must also agree. This system came into place in 2020, after several lawsuits from the relatives of deceased persons, who were outraged that organs were extracted without their consent. In 2024, there were 260 transplantations, of which 237 were from a living donor. "The main problem is refusal of relatives. We also have a very low expression of will. As of January 2025, with an adult population of 11 million, 115,000 people have expressed their will to opt out, and only 8,000 opted in," noted Sitkazinov. All Central Asian countries share similar problems when it comes to posthumous donation; lack of trust in the system and misconceptions about the donations themselves. Until public awareness increases and systems prove to be more transparent and secure the number of organ donations from deceased people is unlikely to grow significantly.
Sustainability Times
19 hours ago
- Sustainability Times
'U.S. Delivers a Monster': 60-Foot Superconducting Magnet Sent to France to Power the Heart of the ITER Fusion Reactor
Illustration of an 18-meter-tall superconducting magnet central to the ITER fusion project. Image generated by AI.
Euronews
2 days ago
- Euronews
These UK scientists are ‘growing colour' using nature's DNA codes
From the vivid red of a parrot's feather to the dreamy blues and purples of Indigo plants, nature is a riot of colour. It has a spectrum to satisfy even the most fashion-forward of humans, so what if there were a way to naturally copy all of these hues? That's precisely what UK-based company Colorifix is working on: a fabric-dyeing process that uses the DNA codes for colours found in nature and teaches microbes to recreate them. Founders Orr Yarkoni and Jim Ajioka were motivated by a research trip to Nepal in 2013, where they saw the toxic impact of chemically synthesised dyes on Kathmandu's rivers. A decade later, Colorfix won recognition as a 2023 finalist for The Earthshot Prize - the global environmental award created by Britain's Prince William. We caught up with the company to find out more about the waste-cutting solution and what they've achieved since stepping into the global spotlight. Before the 19th century, fabric dyes were derived from natural plants and crops, and colourful clothing was considered a luxury. Colorifix is 'bringing the fashion industry back to its roots', in the words of CEO Yarkoni - but with a 21st century set of tools to unlock new pigments. It begins by identifying an interesting colour created naturally by an animal, plant or microbe. By searching public databases, scientists find the 'instructions' for making that colour in the organism's DNA code. They then insert that code into bioengineered microbes like yeast, which are fed with sugar and nitrogen in bioreactors, similar to the way beer is brewed. Over time, these 'microscopic colour factories' can create hundreds to thousands of litres of dye. Finally, the contents of the fermentor are pumped into standard dye machines along with the yarn, fabric, or garment to be dyed. 'Support from The Earthshot Prize not only validates the impact of our solution but also connects us with the network needed for this crucial next phase,' says Andreas Andren, head of business development at Colorifix. Finalists - there are 15 each year, across five categories - join the Prize's 12-month accelerator programme, which includes connections to investors and help to overcome hurdles. 'Biotech is great, but overall expensive to run and scale,' explains Andren. 'Part of the innovation we had to put into play was hardware to make biotechnology scaling competitive with commodity chemical manufacturing. 'Having to solve that problem on top of developing our core technology - the actual dyeing - was definitely the biggest challenge.' Colorfix's solution makes for an interesting intellectual property (IP) case. Patenting organisms that have been recreated using DNA technology is tricky, so the company has instead patented its process of producing, depositing and fixing dye on fabric. 'To reap all the benefits of our technology, such as flexibility and cost parity, a dye house will need to install our proprietary bioreactors on-site,' Andren says. Is the company coming up against incumbents in the industry? 'We are getting more attention from synthetic chemical manufacturers,' he says. 'Some good, some not so good; but the fact that they are starting to pay attention is definitely a sign we are on the right track.' Colorifix has operational capacity in Europe and South America - spread out across several manufacturers - and is aiming to be operational in South Asia within a year. It has partnered with fashion brands like Pangaia and Vollebak to bring products dyed with its technology to market and start increasing demand for sustainable dyes throughout the supply chain. There are other 'big names in the pipeline,' says Andren - but the company is keeping its cards close to its chest for now. The same goes for the new colours it is cooking up. However, he reveals, they successfully dyed greens and oranges during the first part of the year. And the team are extending their application to new materials, including Spiber, made of spider silk protein, and Circulose, an alternative cellulose pulp. New colours will join Colorifix's primary palette of three pigments: one detected in Indigo plants; another, Blushing Rose, made by underwater bacteria; and a third bacteria-born pigment found in soil and deep-sea sediments, named Sunlit Sand. Colouring our clothes with these natural dyes would represent huge progress for an industry that is currently polluting and colouring nature - like Tanzania's Msimbazi River - with chemicals. Colorifix's natural dyes cut chemical pollution by 80 per cent and, when applied to fabrics, they require far fewer rinses than synthetic dyes, ultimately saving vast quantities of water. Tajikistan is home to nearly 14,000 glaciers, but more than a thousand have already disappeared. The country has the largest number of glaciers in Central Asia and sits at the epicentre of regional glacier melt. As the impact grows, Tajikistan is leading the call for action and bringing the issue to the global stage. On the side-lines of the first high-level International Conference on Glaciers' Preservation in Dushanbe, Tajikistan's President Emomali Rahmon proposed launching a major study of the country's glaciers and creating a regional research lab. He also suggested focusing research efforts on the Vanch Yakh Glacier, formerly known as Fedchenko. It is the world's largest continental glacier and has already retreated by more than one kilometre over the past 80 years. "Considering the fact that more than 60% of the region's glaciers are located in Tajikistan, I propose, in collaboration with development partners and research institutes, to organise a comprehensive expedition to study the glaciers of Tajikistan and establish a regional laboratory for glacier research," the president said. The International Conference on Glaciers' Preservation gathered more than 2,000 people from more than 80 countries. Among the high-profile guests were UN Deputy Secretary-General Amina Mohammed, Iran's First Vice President Mohammed Reza Arif, Pakistan's Prime Minister Muhammad Shabaz Sharif and other international leaders. The event marks an important step toward putting the UN's 2025 International Year of Glacier Preservation into action.
